# Neuralink GB-PRIME UK Study Enrolls Seven Patients at UCLH and Newcastle

> clinical trial · REPORTED · 2026-01-01

Neuralink confirmed that seven participants received its N1 brain-computer interface implant at UCLH's National Hospital for Neurology and Neurosurgery as part of the GB-PRIME feasibility study, with surgeries completed between October and December 2025. The study evaluates BCI safety and functionality for people with severe paralysis at two UK NHS sites.

- Company: Neuralink
- Sector: neurotech
- Primary source: https://www.uclh.nhs.uk/news/seven-gb-prime-patients-now-participating-neuralink-trial

---
Source: MedFuel Intel news monitor. Verification tier: REPORTED. Informational only, not investment advice. Corrections: media@medfuelinc.com.